nAscent BioSciences

nAscent BioSciences was a biotechnology company based in San Diego, California, that specialized in the discovery of small molecule therapeutics. The company's research was centered on the inhibition of N-terminal acetyltransferases (NATs), particularly the NatA complex, which is a key regulator of protein function and stability in cancer cells. By utilizing its proprietary nAscent platform, the company sought to develop novel drugs that could disrupt protein-protein interactions essential for tumor growth. Their lead programs were focused on oncology indications where NatA is frequently overexpressed. Although the company made progress in the pre-clinical space, it is currently inactive and its operations have ceased.